Inventor
RON C. KELLY
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07BGeneral methods of organic chemistry18%
C07DHeterocyclic compounds18%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
G01RMeasuring electric variables6%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%
C07CAcyclic or carbocyclic compounds4%
C07KPeptides4%
C30BSingle-crystal growth4%
PatentTitleYear
12,473,329Methods directed to crystalline biomolecules202512,421,234Solid state forms202512,415,806Solid state forms202512,398,133Solid state forms202512,252,486Solid state forms202512,187,700Polymorphs and cocrystals of a cardiac troponin activator202512,000,915Method for conducting solid state NMR on macromolecule-containing solid state formulations202411,958,882Methods directed to crystalline biomolecules202411,926,592Salts and crystal forms of omecamtiv mecarbil202411,827,635Solid state forms202311,465,969Salts and crystal forms of omecamtiv mecarbil202211,236,091Solid state forms2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to AMGEN INC (12)· patent assignee history
2022–2025Patents assigned to CYTOKINETICS INC (2)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 12 | 2022–2025 |
| CYTOKINETICS INC | 2 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2022–2025 |